scholarly journals Multiplex-Heterogeneous Network Embedding for Drug Repositioning

2021 ◽  
Author(s):  
Léo Pio-Lopez
Keyword(s):  
Heterogeneous Networks ◽  
Heterogeneous Network ◽  
Link Prediction ◽  
Drug Target ◽  
Drug Repositioning ◽  
Drug Repurposing ◽  
Network Embedding ◽  
Medical Treatments ◽  
Vector Representations

Drug repositioning (also called drug repurposing) is a strategy for identifying new therapeutic targets for existing drugs. This approach is of great importance in pharmacology as it is a faster and cheaper way to develop new medical treatments. In this paper, we present, to our knowledge, the first application of multiplex-heterogeneous network embedding to drug repositioning. Network embedding learns the vector representations of nodes, opening the whole machine learning toolbox for a wide variety of applications including link prediction, node labelling or clustering. So far, the application of network embedding for drug repositioning focused on heterogeneous networks. Our approach for drug repositioning is based on multiplex-heterogeneous network embedding. Such method allows the richness and complexity of multiplex and heterogeneous networks to be projected in the same vector space. In other words, multiplex-heterogeneous networks aggregate different multi-omics data in the same network representation. We validate the approach on a task of link prediction and on a case study for SARS-CoV2 drug repositioning. Experimental results show that our approach is highly robust and effective for finding new drug-target associations.

scholarly journals MultiVERSE: a multiplex and multiplex-heterogeneous network embedding approach

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Léo Pio-Lopez ◽  
Alberto Valdeolivas ◽  
Laurent Tichit ◽  
Élisabeth Remy ◽  
Anaïs Baudot
Keyword(s):  
Heterogeneous Networks ◽  
Heterogeneous Network ◽  
Link Prediction ◽  
Network Embedding ◽  
Multiplex Networks ◽  
Multiplex Network ◽  
Gene Associations ◽  
Different Types ◽  
Embedding Methods ◽  
Node Embeddings

AbstractNetwork embedding approaches are gaining momentum to analyse a large variety of networks. Indeed, these approaches have demonstrated their effectiveness in tasks such as community detection, node classification, and link prediction. However, very few network embedding methods have been specifically designed to handle multiplex networks, i.e. networks composed of different layers sharing the same set of nodes but having different types of edges. Moreover, to our knowledge, existing approaches cannot embed multiple nodes from multiplex-heterogeneous networks, i.e. networks composed of several multiplex networks containing both different types of nodes and edges. In this study, we propose MultiVERSE, an extension of the VERSE framework using Random Walks with Restart on Multiplex (RWR-M) and Multiplex-Heterogeneous (RWR-MH) networks. MultiVERSE is a fast and scalable method to learn node embeddings from multiplex and multiplex-heterogeneous networks. We evaluate MultiVERSE on several biological and social networks and demonstrate its performance. MultiVERSE indeed outperforms most of the other methods in the tasks of link prediction and network reconstruction for multiplex network embedding, and is also efficient in link prediction for multiplex-heterogeneous network embedding. Finally, we apply MultiVERSE to study rare disease-gene associations using link prediction and clustering. MultiVERSE is freely available on github at https://github.com/Lpiol/MultiVERSE.

scholarly journals DTI-HeNE: a novel method for drug-target interaction prediction based on heterogeneous network embedding

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Yang Yue ◽  
Shan He
Keyword(s):  
Machine Learning ◽  
Heterogeneous Network ◽  
Drug Target ◽  
Prediction Method ◽  
Drug Repurposing ◽  
Graph Embedding ◽  
Multiple Drug ◽  
Network Embedding ◽  
Protein Targets ◽  
Target Interaction

Abstract Background Prediction of the drug-target interaction (DTI) is a critical step in the drug repurposing process, which can effectively reduce the following workload for experimental verification of potential drugs’ properties. In recent studies, many machine-learning-based methods have been proposed to discover unknown interactions between drugs and protein targets. A recent trend is to use graph-based machine learning, e.g., graph embedding to extract features from drug-target networks and then predict new drug-target interactions. However, most of the graph embedding methods are not specifically designed for DTI predictions; thus, it is difficult for these methods to fully utilize the heterogeneous information of drugs and targets (e.g., the respective vertex features of drugs and targets and path-based interactive features between drugs and targets). Results We propose a DTI prediction method DTI-HeNE (DTI based on Heterogeneous Network Embedding), which is specifically designed to cope with the bipartite DTI relations for generating high-quality embeddings of drug-target pairs. This method splits a heterogeneous DTI network into a bipartite DTI network, multiple drug homogeneous networks and target homogeneous networks, and extracts features from these sub-networks separately to better utilize the characteristics of bipartite DTI relations as well as the auxiliary similarity information related to drugs and targets. The features extracted from each sub-network are integrated using pathway information between these sub-networks to acquire new features, i.e., embedding vectors of drug-target pairs. Finally, these features are fed into a random forest (RF) model to predict novel DTIs. Conclusions Our experimental results show that, the proposed DTI network embedding method can learn higher-quality features of heterogeneous drug-target interaction networks for novel DTIs discovery.

Synonymy Expansion Using Link Prediction Methods: A Case Study of Assamese WordNet

2022 ◽  
Vol 21 (1) ◽  
pp. 1-21
Author(s):  
Bornali Phukon ◽  
Akash Anil ◽  
Sanasam Ranbir Singh ◽  
Priyankoo Sarmah
Keyword(s):  
Network Analysis ◽  
Target Word ◽  
Complex Network ◽  
Link Prediction ◽  
Expansion Method ◽  
Prediction Methods ◽  
Network Embedding ◽  
Per Se ◽  
Local Proximity

WordNets built for low-resource languages, such as Assamese, often use the expansion methodology. This may result in missing lexical entries and missing synonymy relations. As the Assamese WordNet is also built using the expansion method, using the Hindi WordNet, it also has missing synonymy relations. As WordNets can be visualized as a network of unique words connected by synonymy relations, link prediction in complex network analysis is an effective way of predicting missing relations in a network. Hence, to predict the missing synonyms in the Assamese WordNet, link prediction methods were used in the current work that proved effective. It is also observed that for discovering missing relations in the Assamese WordNet, simple local proximity-based methods might be more effective as compared to global and complex supervised models using network embedding. Further, it is noticed that though a set of retrieved words are not synonyms per se, they are semantically related to the target word and may be categorized as semantic cohorts.

scholarly journals A review on drug repurposing applicable to COVID-19

2020 ◽  
Author(s):  
Serena Dotolo ◽  
Anna Marabotti ◽  
Angelo Facchiano ◽  
Roberto Tagliaferri
Keyword(s):  
Artificial Intelligence ◽  
Drug Target ◽  
Lower Cost ◽  
Drug Repositioning ◽  
Drug Repurposing ◽  
Chemical Compounds ◽  
The Moment ◽  
New Applications ◽  
Novel Drug ◽  
Small Chemical

Abstract Drug repurposing involves the identification of new applications for existing drugs at a lower cost and in a shorter time. There are different computational drug-repurposing strategies and some of these approaches have been applied to the coronavirus disease 2019 (COVID-19) pandemic. Computational drug-repositioning approaches applied to COVID-19 can be broadly categorized into (i) network-based models, (ii) structure-based approaches and (iii) artificial intelligence (AI) approaches. Network-based approaches are divided into two categories: network-based clustering approaches and network-based propagation approaches. Both of them allowed to annotate some important patterns, to identify proteins that are functionally associated with COVID-19 and to discover novel drug–disease or drug–target relationships useful for new therapies. Structure-based approaches allowed to identify small chemical compounds able to bind macromolecular targets to evaluate how a chemical compound can interact with the biological counterpart, trying to find new applications for existing drugs. AI-based networks appear, at the moment, less relevant since they need more data for their application.

scholarly journals A Network Integration Approach for Drug-Target Interaction Prediction and Computational Drug Repositioning from Heterogeneous Information

2017 ◽  
Author(s):  
Yunan Luo ◽  
Xinbin Zhao ◽  
Jingtian Zhou ◽  
Jinglin Yang ◽  
Yanqing Zhang ◽  
...  
Keyword(s):  
Heterogeneous Network ◽  
Drug Target ◽  
Large Scale ◽  
Molecular Mechanisms ◽  
Inflammatory Diseases ◽  
Drug Repositioning ◽  
Heterogeneous Data ◽  
Heterogeneous Information ◽  
Cox Inhibitors ◽  
New Drug

AbstractThe emergence of large-scale genomic, chemical and pharmacological data provides new opportunities for drug discovery and repositioning. Systematic integration of these heterogeneous data not only serves as a promising tool for identifying new drug-target interactions (DTIs), which is an important step in drug development, but also provides a more complete understanding of the molecular mechanisms of drug action. In this work, we integrate diverse drug-related information, including drugs, proteins, diseases and side-effects, together with their interactions, associations or similarities, to construct a heterogeneous network with 12,015 nodes and 1,895,445 edges. We then develop a new computational pipeline, called DTINet, to predict novel drug-target interactions from the constructed heterogeneous network. Specifically, DTINet focuses on learning a low-dimensional vector representation of features for each node, which accurately explains the topological properties of individual nodes in the heterogeneous network, and then predicts the likelihood of a new DTI based on these representations via a vector space projection scheme. DTINet achieves substantial performance improvement over other state-of-the-art methods for DTI prediction. Moreover, we have experimentally validated the novel interactions between three drugs and the cyclooxygenase (COX) protein family predicted by DTINet, and demonstrated the new potential applications of these identified COX inhibitors in preventing inflammatory diseases. These results indicate that DTINet can provide a practically useful tool for integrating heterogeneous information to predict new drug-target interactions and repurpose existing drugs. The source code of DTINet and the input heterogeneous network data can be downloaded from http://github.com/luoyunan/DTINet.

scholarly journals Drug REpurposing using AI/ML tools - for Rare Diseases (DREAM-RD): A case study with Fragile X Syndrome (FXS)

2020 ◽  
Author(s):  
Kavitha Agastheeswaramoorthy ◽  
Aarti Sevilimedu
Keyword(s):  
Fragile X Syndrome ◽  
Drug Repositioning ◽  
Fragile X ◽  
Drug Repurposing ◽  
Machine Learning Algorithms ◽  
Specific Gene ◽  
Drug Induced ◽  
Approved Drugs ◽  
Disease Specific

AbstractDrug repositioning is emerging as an increasingly relevant option for rare disease therapy and management. Various methods for identifying suitable drug candidates have been tried and range from clinical symptomatic repurposing to data driven strategies which are based on the disease-specific gene or protein expression, modification, signalling and physiological perturbation profiles. The use of Artificial Intelligence (AI) and machine learning algorithms (ML) allows one to combine diverse data sets, and extract disease-specific data profiles which may not be intuitive or apparent from a subset of data. In this case study with Fragile X syndrome and autism, we have used multiple computational methodologies to extract profiles, which are then combined to arrive at a comprehensive signature (disease DEG). This DEG was then used to interrogate the large collection of drug-induced perturbation profiles present in public databases, to find appropriate small molecules to reverse or mimic the disease-profiles. We have labelled this pipeline Drug Repurposing using AI/ML tools - for Rare Diseases (DREAM-RD). We have shortlisted over 100 FDA approved drugs using the aforementioned pipeline, which may potentially be useful to ameliorate autistic phenotypes associated with FXS.

scholarly journals DTI-SNNFRA: Drug-target interaction prediction by shared nearest neighbors and fuzzy-rough approximation

PLoS ONE ◽  
2021 ◽  
Vol 16 (2) ◽  
pp. e0246920
Author(s):  
Sk Mazharul Islam ◽  
Sk Md Mosaddek Hossain ◽  
Sumanta Ray
Keyword(s):  
Drug Discovery ◽  
Drug Target ◽  
Drug Repositioning ◽  
Geometric Mean ◽  
Imbalanced Data ◽  
Drug Repurposing ◽  
Search Space ◽  
Classification Model ◽  
Target Interaction ◽  
Rough Approximation

In-silico prediction of repurposable drugs is an effective drug discovery strategy that supplements de-nevo drug discovery from scratch. Reduced development time, less cost and absence of severe side effects are significant advantages of using drug repositioning. Most recent and most advanced artificial intelligence (AI) approaches have boosted drug repurposing in terms of throughput and accuracy enormously. However, with the growing number of drugs, targets and their massive interactions produce imbalanced data which may not be suitable as input to the classification model directly. Here, we have proposed DTI-SNNFRA, a framework for predicting drug-target interaction (DTI), based on shared nearest neighbour (SNN) and fuzzy-rough approximation (FRA). It uses sampling techniques to collectively reduce the vast search space covering the available drugs, targets and millions of interactions between them. DTI-SNNFRA operates in two stages: first, it uses SNN followed by a partitioning clustering for sampling the search space. Next, it computes the degree of fuzzy-rough approximations and proper degree threshold selection for the negative samples’ undersampling from all possible interaction pairs between drugs and targets obtained in the first stage. Finally, classification is performed using the positive and selected negative samples. We have evaluated the efficacy of DTI-SNNFRA using AUC (Area under ROC Curve), Geometric Mean, and F1 Score. The model performs exceptionally well with a high prediction score of 0.95 for ROC-AUC. The predicted drug-target interactions are validated through an existing drug-target database (Connectivity Map (Cmap)).

scholarly journals Coupled matrix–matrix and coupled tensor–matrix completion methods for predicting drug–target interactions

2020 ◽  
Author(s):  
Maryam Bagherian ◽  
Renaid B Kim ◽  
Cheng Jiang ◽  
Maureen A Sartor ◽  
Harm Derksen ◽  
...  
Keyword(s):  
Matrix Factorization ◽  
Drug Target ◽  
Drug Repositioning ◽  
Matrix Completion ◽  
Area Under The Curve ◽  
Drug Repurposing ◽  
Computational Prediction ◽  
Comprehensive Information ◽  
The Matrix ◽  
Benchmark Datasets

Abstract Predicting the interactions between drugs and targets plays an important role in the process of new drug discovery, drug repurposing (also known as drug repositioning). There is a need to develop novel and efficient prediction approaches in order to avoid the costly and laborious process of determining drug–target interactions (DTIs) based on experiments alone. These computational prediction approaches should be capable of identifying the potential DTIs in a timely manner. Matrix factorization methods have been proven to be the most reliable group of methods. Here, we first propose a matrix factorization-based method termed ‘Coupled Matrix–Matrix Completion’ (CMMC). Next, in order to utilize more comprehensive information provided in different databases and incorporate multiple types of scores for drug–drug similarities and target–target relationship, we then extend CMMC to ‘Coupled Tensor–Matrix Completion’ (CTMC) by considering drug–drug and target–target similarity/interaction tensors. Results: Evaluation on two benchmark datasets, DrugBank and TTD, shows that CTMC outperforms the matrix-factorization-based methods: GRMF, $L_{2,1}$-GRMF, NRLMF and NRLMF$\beta $. Based on the evaluation, CMMC and CTMC outperform the above three methods in term of area under the curve, F1 score, sensitivity and specificity in a considerably shorter run time.

Sign in / Sign up

Export Citation Format

Share Document